SCHEMBL6460491

SCHEMBL6460491

Cc1c(C(=O)O)nc(-c2ccccc2OC(F)(F)F)n1CC1CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 1/20 0.42
HSD17B10 Q99714 2/20 0.41
KCNH2 Q12809 1/20 0.41
SCN9A Q15858 1/20 0.41
POLB P06746 1/20 0.41
MDM2 Q00987 1/20 0.40
HCRTR1 O43613 6/20 0.40
HCRTR2 O43614 6/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
KMT2A Q03164 2/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3921909 0.86 TNK2 (0.42) TNK2HSD17B10KCNH2SCN9APOLB
SCHEMBL27643649 0.82 MDM2 (0.43) SCN9AMDM2HCRTR1HCRTR2
SCHEMBL4371560 0.79 ALDH1A1 (0.48) TNK2HSD17B10KCNH2SCN9APOLB
SCHEMBL4371558 0.79 ALDH1A1 (0.48) TNK2HSD17B10KCNH2SCN9APOLB
SCHEMBL4372532 0.79 ALDH1A1 (0.48) TNK2HSD17B10KCNH2SCN9APOLB
SCHEMBL4371432 0.77 CNR1 (0.42) HSD17B10MDM2ALDH1A1KDM4EHTT
SCHEMBL4375154 0.75 PTGER1 (0.43) HSD17B10POLBALDH1A1GAAHTT
SCHEMBL3921031 0.74 CNR1 (0.40) MDM2
SCHEMBL4368746 0.74 CNR2 (0.46) HSD17B10POLBALDH1A1KDM4EGAA
SCHEMBL4382166 0.73 ALDH1A1 (0.47) TNK2HSD17B10KCNH2SCN9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583742-A1 NOVEL CB 1 RECEPTOUR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060870-A1 NOVEL CB 1 RECEPTOUR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed